Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 86

1.

A clinical trial of Fluosol DA 20% in advanced squamous cell carcinoma of the head and neck.

Rose C, Lustig R, McIntosh N, Teicher B.

Int J Radiat Oncol Biol Phys. 1986 Aug;12(8):1325-7.

PMID:
3759553
2.

Phase I/II study of Fluosol-DA and 100% oxygen as an adjuvant to radiation in the treatment of advanced squamous cell tumors of the head and neck.

Lustig R, McIntosh-Lowe N, Rose C, Haas J, Krasnow S, Spaulding M, Prosnitz L.

Int J Radiat Oncol Biol Phys. 1989 Jun;16(6):1587-93.

PMID:
2722598
3.

Treatment-related toxicities with Fluosol-DA 20% infusion during radiation in advanced head and neck malignancies.

Campbell BH, Janjan NA, Byhardt RW, Toohill RJ.

Laryngoscope. 1990 Mar;100(3):237-9.

PMID:
2407916
4.

Simultaneous integrated boost intensity-modulated radiotherapy for locally advanced head-and-neck squamous cell carcinomas: II--clinical results.

Lauve A, Morris M, Schmidt-Ullrich R, Wu Q, Mohan R, Abayomi O, Buck D, Holdford D, Dawson K, Dinardo L, Reiter E.

Int J Radiat Oncol Biol Phys. 2004 Oct 1;60(2):374-87.

PMID:
15380569
5.

Accelerated radiotherapy with delayed concomitant boost in locally advanced squamous cell carcinoma of the head and neck.

MacKenzie R, Balogh J, Choo R, Franssen E.

Int J Radiat Oncol Biol Phys. 1999 Oct 1;45(3):589-95.

PMID:
10524410
6.

Preoperative cisplatin and accelerated hyperfractionated radiation induces high tumor response and control rates in patients with advanced head and neck cancer.

Wanebo HJ, Glicksman AS, Landman C, Slotman G, Doolittle C, Clark J, Koness RJ.

Am J Surg. 1995 Nov;170(5):512-6.

PMID:
7485745
7.

Efficacy of targeted supradose cisplatin and concomitant radiation therapy for advanced head and neck cancer: the Memphis experience.

Robbins KT, Kumar P, Regine WF, Wong FS, Weir AB 3rd, Flick P, Kun LE, Palmer R, Murry T, Fontanesi J, Ferguson R, Thomas R, Hartsell W, Paig CU, Salazar G, Norfleet L, Hanchett CB, Harrington V, Niell HB.

Int J Radiat Oncol Biol Phys. 1997 May 1;38(2):263-71.

PMID:
9226312
8.

Smart (simultaneous modulated accelerated radiation therapy) boost: a new accelerated fractionation schedule for the treatment of head and neck cancer with intensity modulated radiotherapy.

Butler EB, Teh BS, Grant WH 3rd, Uhl BM, Kuppersmith RB, Chiu JK, Donovan DT, Woo SY.

Int J Radiat Oncol Biol Phys. 1999 Aug 1;45(1):21-32.

PMID:
10477002
9.

Accelerated hyperfractionated irradiation with concomitant boost for stage II laryngeal cancer and locally advanced head and neck cancer.

Ishii K, Tashiro M, Hosono M, Fukuda H, Takada Y, Kondo S, Inoue Y, Iguchi H, Kusuki M, Yamane H.

Acta Otolaryngol Suppl. 2004 Oct;(554):62-6.

PMID:
15513514
11.

Normobaric oxygen as a sensitizer in radiotherapy for advanced head and neck cancer.

Zajusz A, Maciejewski B, Hliniak A.

Neoplasma. 1995;42(3):137-40.

PMID:
7637824
12.

Final report of a pilot trial of accelerated radiotherapy plus concurrent 96-hour infusional paclitaxel for locally advanced head and neck cancer.

Bucci MK, Rosenthal DI, Hershock D, Metz J, Devine P, Kligerman MM, Machtay M.

Am J Clin Oncol. 2004 Dec;27(6):595-602.

PMID:
15577438
13.

Reactions of tumors and normal tissues in mice to irradiation in the presence and absence of a perfluorochemical emulsion.

Rockwell S, Mate TP, Irvin CG, Nierenburg M.

Int J Radiat Oncol Biol Phys. 1986 Aug;12(8):1315-8.

PMID:
3093416
14.

The use of carboplatin and paclitaxel with daily radiotherapy in patients with locally advanced squamous cell carcinomas of the head and neck.

Suntharalingam M, Haas ML, Conley BA, Egorin MJ, Levy S, Sivasailam S, Herman JM, Jacobs MC, Gray WC, Ord RA, Aisner JA, Van Echo DA.

Int J Radiat Oncol Biol Phys. 2000 Apr 1;47(1):49-56.

PMID:
10758304
15.

Bioreductive alkylating agent porfiromycin in combination with radiation therapy for the management of squamous cell carcinoma of the head and neck.

Haffty BG, Son YH, Wilson LD, Papac R, Fischer D, Rockwell S, Sartorelli AC, Ross D, Sasaki CT, Fischer JJ.

Radiat Oncol Investig. 1997;5(5):235-45.

PMID:
9372546
16.

A phase I trial of 96-hour paclitaxel infusion plus accelerated radiotherapy of unrespectable head and neck cancer.

Machtay M, Aviles V, Kligerman MM, Treat J, Weinstein GS, Weber RS, Mirza N, Chalian AA, Rosenthal DI.

Int J Radiat Oncol Biol Phys. 1999 May 1;44(2):311-5.

PMID:
10760424
17.

Irradiation with misonidazole and hyperbaric oxygen: final report on a randomized trial in advanced head and neck cancer.

Sealy R, Cridland S, Barry L, Norris R.

Int J Radiat Oncol Biol Phys. 1986 Aug;12(8):1343-6.

PMID:
3531113
18.
19.
20.

Phase II study of induction and adjuvant chemotherapy for squamous cell carcinoma of the head and neck. A long-term analysis for the Illinois Cancer Center.

Athanasiadis I, Taylor S 4th, Vokes EE, Pelzer HJ, Rademaker A, Mittal BB, Ganzenko N, Blough R, Lester EP, Kies MS.

Cancer. 1997 Feb 1;79(3):588-94.

PMID:
9028372

Supplemental Content

Support Center